Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation

Circulation Research

Volumn 90, Issue 2, 2002, Pages 151-157

  Rybalkin, Sergei D ^a   Rybalkina, Irina ^a   Beavo, Joseph A ^a   Bornfeldt, Karin E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

cAMP; cGMP; Collagen; Phosphodiesterase inhibitor

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COLLAGEN; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR;

ARTERY INTIMA PROLIFERATION; ARTERY MUSCLE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL CYCLE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DNA SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE FIBER;

AORTA; CELL DIVISION; CELLS, CULTURED; COLLAGEN TYPE I; ENZYME INDUCTION; ENZYME INHIBITORS; HUMANS; INFANT, NEWBORN; ISOENZYMES; MUSCLE, SMOOTH, VASCULAR; PHOSPHORIC DIESTER HYDROLASES;

EID: 0037040155     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh0202.104108     Document Type: Article

References (35)

1. The pathogenesis of atherosclerosis: A perspective for the 1990s
2. Diabetes as an atherogenic factor
3. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: Lack of direct growth promoting effects of high glucose levels
4. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation
5. Molecular pathways of cyclic nucleotide-induced inhibition of arterial smooth muscle cell proliferation
6. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
7. Regulation of cAMP and cGMP signaling: New phosphodiesterases and new functions
8. Isolation and characterization of cDNAs corresponding to two human calcium, calmodulin-regulated, 3′,5′-cyclic nucleotide phosphodiesterases
9. The calmodulin-dependent phosphodiesterase gene PDE1C encodes several functionally different splice variants in a tissue-specific manner
10. Induction of a calcium/calmodulin-dependent phosphodiesterase during phytohemagglutinin-stimulated lymphocyte mitogenesis
11. Inhibition of calmodulin dependent phosphodiesterase induces apoptosis in human leukemic cells
12. Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype
13. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors
14. Immortalization of primary human smooth muscle cells
15. Dual expression and differential regulation of phosphodiesterase 3A and phosphodiesterase 3B in human vascular smooth muscle: Implications for phosphodiesterase 3 inhibition in human cardiovascular tissue
16. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells
17. Fibrillar collagen specifically regulates human vascular smooth muscle cell genes involved in cellular responses and the pericellular matrix environment
18. Milrinone, a phosphodiesterase inhibitor, suppresses intimal thickening after photochemically induced endothelial injury in the mouse femoral artery
19. Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double-injury model
20. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors
21. Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells
22. Inhibition of platelet-derived growth factor induced mitogenesis by phosphodiesterase 3 inhibitors: Role of protein kinase A in vascular smooth muscle cell mitogenesis
23. Effect of CI-930 [3-(2H)-pyridazinone-4,5-dihydro-6-[4-(IH-imidazolyl) phenyl]-5-methyl-monohydrochloride] and rolipram on human coronary artery smooth muscle cell proliferation
24. Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation
25. Antimitogenic actions of organic nitrates are potentiated by sildenafil and mediated via activation of protein kinase A
26. Protein kinase A antagonizes platelet-derived growth factor induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells
27. cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells
28. Cyclic AMP inhibits Akt activity by blocking the membrane localization of pdk1
29. Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle
30. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury
31. cAMP pulse during preservation inhibits the late development of cardiac isograft and allograft vasculopathy
32. 8-Chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo
33. Effect of phosphodiesterase inhibitors on human arteries in vitro
34. Involvement of cyclic nucleotide dependent protein kinases in cyclic AMP-mediated vasorelaxation
35. Phosphodiesterase inhibition improves agonist-induced relaxation of hypertensive pulmonary arteries